A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE3

Conditions

Allergic Rhinitis, Seasonal

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongnan Hospital of Wuhan university, Wuhan, Hubei, China
Contact: Study coordinator (project manager) · dongjie@genrixbio.com · 021-50805988-8039
Contact: Principal Investigator (Zheng Liu, PHD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

Allergic Conjunctivitis

Abroad (travel likely)RecruitingPHASE3

Andover, United States · Lincoln, United States

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China

PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

Rhinitis Allergic

Abroad (travel likely)RecruitingPHASE2

Almaty, Kazakhstan

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure

Seasonal Allergic Rhinitis (SAR)

Abroad (travel likely)RecruitingPHASE2

Mississauga, Canada